BRPI0418749A - composição herbal - Google Patents

composição herbal

Info

Publication number
BRPI0418749A
BRPI0418749A BRPI0418749-0A BRPI0418749A BRPI0418749A BR PI0418749 A BRPI0418749 A BR PI0418749A BR PI0418749 A BRPI0418749 A BR PI0418749A BR PI0418749 A BRPI0418749 A BR PI0418749A
Authority
BR
Brazil
Prior art keywords
herbal composition
herbal
composition
bupleurum
thuja
Prior art date
Application number
BRPI0418749-0A
Other languages
English (en)
Inventor
Karina Anna Hilterman
Original Assignee
Lavender Hill Projects Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lavender Hill Projects Pty Ltd filed Critical Lavender Hill Projects Pty Ltd
Publication of BRPI0418749A publication Critical patent/BRPI0418749A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçãO HERBAL". A presente invenção refere-se a uma composição herbal compreendendo extratos de thuja, bupleurum, Echinacea, calendula, licorice e hypericum; formulações contendo a composição herbal e a utilização de uma composição herbal para aliviar, tratar e/ou prevenir sintomas associados a, ou causados por, infecções virais.
BRPI0418749-0A 2003-04-16 2004-04-14 composição herbal BRPI0418749A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ52542503 2003-04-16
PCT/AU2004/000489 WO2004091638A1 (en) 2003-04-16 2004-04-14 Herbal composition

Publications (1)

Publication Number Publication Date
BRPI0418749A true BRPI0418749A (pt) 2007-09-11

Family

ID=33297572

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418749-0A BRPI0418749A (pt) 2003-04-16 2004-04-14 composição herbal

Country Status (9)

Country Link
US (1) US20070212432A1 (pt)
EP (1) EP1771186A1 (pt)
CN (1) CN1960743A (pt)
AU (1) AU2004229119A1 (pt)
BR (1) BRPI0418749A (pt)
CA (1) CA2562789A1 (pt)
IL (1) IL178542A0 (pt)
MX (1) MXPA06011905A (pt)
WO (1) WO2004091638A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1752543A1 (en) 2000-01-20 2007-02-14 Archer-Daniels-Midland Company Process for making a variety of l-lysine feed supplements
US7498049B1 (en) * 2007-01-03 2009-03-03 Shmuel Gonen Topical treatment of acne with combined herbal extracts and minerals
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
RS20100392A3 (en) 2010-09-06 2012-12-31 Pavlov, Aleksandar Procedure for obtaining herbal preparation based on herbal mixture extract for application on skin and herbal preparation obtained thereof
EP2793848B1 (en) 2011-12-19 2019-06-26 Mary Kay, Inc. Navy bean extract to whiten the skin and improve skin tone
CN102961444A (zh) * 2012-12-16 2013-03-13 刘艳 一种治疗鼻-鼻窦炎复方制剂
US9849077B2 (en) 2014-03-10 2017-12-26 Mary Kay Inc. Skin lightening compositions
CN109939178A (zh) * 2019-03-26 2019-06-28 孟繁华 靶向抑制非洲猪瘟病毒增殖的活性组合物的制备方法
CN110201150A (zh) * 2019-07-12 2019-09-06 广州莎蔓生物科技有限公司 一种增加人体细胞活性抗hpv的药物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin

Also Published As

Publication number Publication date
IL178542A0 (en) 2007-02-11
EP1771186A1 (en) 2007-04-11
US20070212432A1 (en) 2007-09-13
CA2562789A1 (en) 2004-10-28
AU2004229119A1 (en) 2004-10-28
CN1960743A (zh) 2007-05-09
WO2004091638A1 (en) 2004-10-28
MXPA06011905A (es) 2007-04-16

Similar Documents

Publication Publication Date Title
PL375621A1 (pl) Kompozycje farmaceutyczne zawierające flawonoidy i mentol
CR10099A (es) Inmunoglobulinas dirigidas contra nogo
BRPI0414062A (pt) uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv
BRPI0607017B8 (pt) composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
CL2004000930A1 (es) Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos.
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
DOP2002000429A (es) Imidazotriazinas
BRPI0619153B8 (pt) derivados de 4-amino-pirroltriazina substituída, e composição farmacêutica
GT199900203A (es) Composiciones de celecoxib.
BRPI0414428A (pt) composições farmacêuticas
DE60143857D1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
EA200970916A1 (ru) Соединения 5,6-дигидро-1н-пиридин-2-она
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
DK1089744T3 (da) Neurobeskyttende præparat til forebyggelse og/eller behandling af nervøse og adfærdsmæssige ændringer på grund af angsttilstande eller depression omfattende acetyl-L-carnitin og hypericin
BRPI0418749A (pt) composição herbal
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
BRPI0415123A (pt) uso de l-butilftalida e respectiva composição farmacêutica
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
DE602005019416D1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
CL2004000535A1 (es) Composicion farmaceutica que comprende rapamicina o un derivado de rapamicina y pimecrolimus; y su uso para el tratamiento de enfermedad inflamatoria del intestino.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A,5A,6A E 7A ANUIDADES(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.